Company intelligence / Profile preview

Biem İlaç

Ankara, Ankara, Turkeybiemilac.com.tr ↗
Ownership
Private
Employees
~200
Development stage
Other
01

Overview

Biem İlaç is a prominent Turkish pharmaceutical company established in 1990 and headquartered in Ankara. The company specializes in the marketing, sales, and distribution of high-tech pharmaceutical products across several critical therapeutic areas, including oncology, hematology, radiology, and nephrology. Biem İlaç serves as a strategic partner for international life science companies seeking to enter the Turkish market, providing expertise in regulatory affairs and commercialization. Their portfolio includes a wide range of specialized treatments, from chemotherapy agents to advanced contrast media for diagnostic imaging. The company is committed to improving patient access to essential medicines through its extensive distribution network and professional medical teams.

Therapeutic areas
HematologyNephrologyImmunologyOtherRare DiseasesOncology
Modalities
Small moleculeMonoclonal antibodyBiologic
Industry
Biotech
02

Drug pipeline

1 asset

gadoteric acid

Unknown
03

Partnerships

GuerbetVarious international biotech and biosimilar manufacturers

Beyond the preview

Go deeper on Biem İlaç.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biem İlaç.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call